Reuters logo
BRIEF-Baxter announces U.S. FDA approval, commercial launch of ready-to-use clindamycin injection in saline
June 7, 2017 / 3:40 PM / 3 months ago

BRIEF-Baxter announces U.S. FDA approval, commercial launch of ready-to-use clindamycin injection in saline

June 7 (Reuters) - Baxter International Inc

* Baxter announces U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline

* Baxter announces U.S. FDA approval and commercial launch of ready-to-use clindamycin injection in saline

* Baxter International - FDA approval and commercial launch of ready-to-use clindamycin injection in saline in three commonly prescribed formulations

* Baxter International Inc- remains committed to providing additional premixes in an effort to advance pharmacy efficiency and patient care.

* Baxter International Inc - Baxter’s ready-to-use clindamycin injection in saline is now available to customers in United States Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below